Clinical Trials Search | Clareo Health

Showing 1-1 of 1 trials

Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer

NCT05872204

The purpose of this study is to assess the efficacy and safety of abemaciclib and letrozole for treatment of estrogen receptor-positive rare ovarian cancer.

Low Grade Serous Ovarian CarcinomaAdult Type Granulosa Cell Tumor

Universitaire Ziekenhuizen KU Leuven100 participantsStarted Nov 2023

Liège, Liège, Belgium • Ghent, Oost-Vlaanderen, Belgium • Leuven, Vlaams-Brabant, Belgium +9 more locations

Data from ClinicalTrials.govTerms

Filters

Filters

Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer

Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer